Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome

Table 3

ROC analysis and diagnostic screening tests were used to determine the cutoff point for endocan, HSI, and FLI.

Steatosis present vs. not present	AUC	value	Cutoff	Sensitivity	Specificity	PPV+	PPV-
Endocan	0.867	<0.001	122.583	71.79	90.0	93.3	62.1
HSI	0.814	<0.001	>16.67	92.3	60.00	81.8	80.00
FLI	0.893	<0.001	>40.86	73.7	100.00	100.00	54.5

ROC: receiver operating system; HSI: hepatic steatosis index; FLI: fatty liver index; AUC: area under curve. Statistical significance: and .